skip to Main Content


Early-stage biotechnology, pharmaceutical, medical device, diagnostic, or health information technology companies focused on curing cancer developing innovative products and platforms are eligible to apply.

Companies will be evaluated based on their management teams, control or access to owned, licensed or protectable IP/technology, development plans and ability to demonstrate a validated market need.


All competition participants will be responsible for taking the proper steps to protect their intellectual property. The competition is a public event. Judges, organizers, sponsors, and other individuals involved in the event do not sign non-disclosure agreements.

The ownership of the technology must be identified. Teams will not be permitted to present ideas based on science and technology owned by third parties who have not licensed their technology to the presenting company (or in the case where negotiations are ongoing, expressed a clear intent to license the technology to the participants, pending agreement on terms). The organizers of the competition may disqualify any team failing to comply with this rule and shall be held harmless due to such action.


Early stage life sciences, medical device, diagnostics and/or health information technology company with a focus on oncology seeking pre-venture or early-venture funding.

Back To Top